Clinical Features and Risk Factors for Atazanavir (ATV)-Associated Urolithiasis: A Case-Control Study

• Matthieu Lafaurie ,

  * E-mail: matthieu.lafaurie@sls.aphp.fr

  Affiliation Department of Infectious Diseases, Saint-Louis Hospital, Paris, France, and University of Paris Diderot Paris 7, Sorbonne Paris Cité, INSERM U941, Paris, France

  ⨯
• Barbara De Sousa,

  Affiliation Department of Infectious Diseases, Saint-Louis Hospital, Paris, France, and University of Paris Diderot Paris 7, Sorbonne Paris Cité, INSERM U941, Paris, France

  ⨯
• Diane Ponscarme,

  Affiliation Department of Infectious Diseases, Saint-Louis Hospital, Paris, France, and University of Paris Diderot Paris 7, Sorbonne Paris Cité, INSERM U941, Paris, France

  ⨯
• Nathanael Lapidus,

  Affiliation AP-HP, Hôpital Saint Louis, Service de Biostatistique et Information Médicale, Paris, France, and INSERM, UMR_S 1136, Institut Pierre-Louis d′Epidémiologie et de Santé Publique, Paris, France, and Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre-Louis d′Epidémiologie et de Santé Publique, Paris, France

  ⨯
• Michel Daudon,

  Affiliation Laboratory of Clinical Physiology, Tenon Hospital, Paris, France

  ⨯
• Laurence Weiss,

  Affiliation AP-HP, Service of Clinical Immunology, Georges Pompidou European Hospital and University of Paris Descartes, Sorbonne Paris Cité, Paris, France

  ⨯
• Christophe Rioux,

  Affiliation Department of Infectious Diseases, Bichat Hospital, Paris, France

  ⨯
• Erwan Fourn,

  Affiliation Internal Medicine Department, Bicetre Hospital, Le Kremlin Bicetre, France

  ⨯
• Christine Katlama,

  Affiliation Department of Infectious Diseases, Pitie-Salpetriere Hospital, Paris, France

  ⨯
• Jean-Michel Molina

  Affiliation Department of Infectious Diseases, Saint-Louis Hospital, Paris, France, and University of Paris Diderot Paris 7, Sorbonne Paris Cité, INSERM U941, Paris, France

  ⨯